# Effects of Enamel Matrix Derivative in the Treatment of Peri-implant Mucositis

> **NCT06725095** · NA · ENROLLING_BY_INVITATION · sponsor: **University of Catania** · enrollment: 54 (estimated)

## Conditions studied

- Mucositis
- Peri Implant Mucositis

## Interventions

- **OTHER:** Placebo gel
- **OTHER:** Enamel Matrix Proteins Derivative

## Key facts

- **NCT ID:** NCT06725095
- **Lead sponsor:** University of Catania
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-12-05
- **Primary completion:** 2025-02-01
- **Final completion:** 2025-06-05
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06725095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06725095, "Effects of Enamel Matrix Derivative in the Treatment of Peri-implant Mucositis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06725095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*